Mechanical forces in diabetic kidney disease: A trigger for impaired glucose metabolism

Journal of the American Society of Nephrology

Volumn 18, Issue 8, 2007, Pages 2226-2232

  Gnudi, Luigi ^a   Thomas, Stephen M ^a   Viberti, Giancarlo ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE TRANSPORTER 1; TRANSFORMING GROWTH FACTOR BETA1;

CAPILLARY PRESSURE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE MODEL; EXTRACELLULAR MATRIX; GLOMERULUS CAPILLARY; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; HUMAN; HYPERGLYCEMIA; MECHANICS; MESANGIUM CELL; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 34547636295     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2006121362     Document Type: Review

References (93)

1. Zimmet P: The burden of type 2 diabetes: Are we doing enough? Diabetes Metab 29: 6S9-6S18, 2003
2. Ritz E, Tarng DC: Renal disease in type 2 diabetes. Nephrol Dial Transplant 16[Suppl 5]: 11-18, 2001
3. Jones CA, Krolewski AS, Rogus J, Xue JL, Collins A, Warram JH: Epidemic of end-stage renal disease in people with diabetes in the United States population: Do we know the cause? Kidney Int 67: 1684-1691, 2005
4. Cooper ME: Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy. Diabetologia 44: 1957-1972, 2001
5. Gnudi L, Viberti G, Raij L, Rodriguez V, Burt D, Cortes P, Hartley B, Thomas S, Maestrini S, Gruden G: GLUT-1 overexpression: Link between hemodynamic and metabolic factors in glomerular injury? Hypertension 42: 19-24, 2003
6. Keen H, Chlouverakis C, Fuller J, Jarrett RJ: The concomitants of raised blood sugar: Studies in newly-detected hyperglycaemics. II. Urinary albumin excretion, blood pressure and their relation to blood sugar levels. Guys Hosp Rep 118: 247-254, 1969
7. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986, 1993
8. Genuth S: Insights from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study on the use of intensive glycemic treatment to reduce the risk of complications of type 1 diabetes. Endocr Pract 12[Suppl 1]: 34-41, 2006
9. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UK-PDS 33). Lancet 352: 837-853, 1998
10. The Microalbuminuria Collaborative Study Group: Predictors of the development of microalbuminuria in patients with type 1 diabetes mellitus: A seven-year prospective study. Diabet Med 16: 918-925, 1999
11. Haneda M, Kikkawa R, Togawa M, Koya D, Kajiwara N, Uzu T, Shigeta Y: High blood pressure is a risk factor for the development of microalbuminuria in Japanese subjects with non-insulin-dependent diabetes mellitus. J Diabetes Complications 6: 181-185, 1992
12. Lewis JB, Berl T, Bain RP, Rohde RD, Lewis EJ: Effect of intensive blood pressure control on the course of type 1 diabetic nephropathy. Am J Kidney Dis 34: 809-817, 1999
13. Pohl MA, Blumenthal S, Cordonnier DJ, De Alvaro F, Deferrari G, Eisner G, Esmatjes E, Gilbert RE, Hunsicker LG, de Faria JB, Mangili R, Moore J Jr, Reisin E, Ritz E, Schernthaner G, Spitalewitz S, Tindall H, Rodby RA, Lewis EJ: Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial: Clinical implications and limitations. J Am Soc Nephrol 16: 3027-3037, 2005
14. Alaveras AE, Thomas SM, Sagriotis A, Viberti GC: Promoters of progression of diabetic nephropathy: The relative roles of blood glucose and blood pressure control. Nephrol Dial Transplant 12[Suppl 2]: 71-74, 1997
15. Ito S, Abe K: Contractile properties of afferent and efferent arterioles. Clin Exp Pharmacol Physiol 24: 532-535, 1997
16. Hostetter TH, Troy JL, Brenner BM: Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int 19: 410-415, 1981
17. Hostetter TH, Rennke HG, Brenner BM: The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med 72: 375-380, 1982
18. Zatz R, Rentz Dunn B, Mayer TW, Anderson S, Rennke HG, Brenner BM: Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 77: 1925-1930, 1986
19. De Vriese AS, Stoenoiu MS, Elger M, Devuyst O, Vanholder R, Kriz W, Lameire NH: Diabetes-induced microvascular dysfunction in the hydronephrotic kidney: Role of nitric oxide. Kidney Int 60: 202-210, 2001
20. Kagami S, Border WA, Miller DE, Noble NA: Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. J Clin Invest 93: 2431-2437, 1994
21. Raij L: The pathophysiologic basis for blocking the renin-angiotensin system in hypertensive patients with renal disease. Am J Hypertens 18: 95S-99S, 2005
22. Sharma K, Cook A, Smith M, Valancius C, Inscho EW: TGF-beta impairs renal autoregulation via generation of ROS. Am J Physiol Renal Physiol 288: F1069-F1077, 2005
23. Anderson S, Vora JP: Current concepts of renal hemodynamics in diabetes. J Diabetes Complications 9: 304-307, 1995
24. Maddox DA, Brenner BM: Glomerular ultrafiltration. In: The Kidney, 6th Ed., edited by Brenner BM, Rector FC Jr, Philadelphia, W.B. Saunders Co., 2000, pp 319-374
25. Azar S, Limas C, Iway J, Weller D: Single nephron dynamics during high sodium intake and early hypertension in Dahl rats. Jpn Heart J 20[Suppl 1]: 138-140, 1979
26. Takenaka T, Forster H, De Micheli A, Epstein M: Impaired myogenic responsiveness of renal microvessels in Dahl salt-sensitive rats. Circ Res 71: 471-480, 1992
27. Faraj AH, Morley AR: Remnant kidney pathology after five-sixth nephrectomy in rat. I. A biochemical and morphological study. APMIS 100: 1097-1105, 1992
28. Hayakawa H, Raij L: Nitric oxide synthase activity and renal injury in genetic hypertension. Hypertension 31: 266-270, 1998
29. Arendshorst WJ: Autoregulation of renal blood flow in spontaneously hypertensive rats. Circ Res 44: 344-349, 1979
30. Raij L, Azar S, Keane WF: Role of hypertension in progressive glomerular immune injury. Hypertension 7: 398-404, 1985
31. Mogensen CE: Early glomerular hyperfiltration in insulin-dependent diabetics and late nephropathy. Scand J Clin Lab Invest 46: 201-206, 1986
32. Wiseman MJ, Saunders AJ, Keen H, Viberti G: Effect of blood glucose control on increased glomerular filtration rate and kidney size in insulin-dependent diabetes. N Engl J Med 312: 617-621, 1985
33. Yip JW, Jones SL, Wiseman MJ, Hill C, Viberti G: Glomerular hyperfiltration in the prediction of nephropathy in IDDM: A 10-year follow-up study. Diabetes 45: 1729-1733, 1996
34. Zerbini G, Bonfanti R, Meschi F, Bognetti E, Paesano PL, Gianolli L, Querques M, Maestroni A, Calori G, Del MA, Fazio F, Luzi L, Chiumello G: Persistent renal hypertrophy and faster decline of glomerular filtration rate precede the development of microalbuminuria in type 1 diabetes. Diabetes 55: 2620-2625, 2006
35. Berg UB, Torbjornsdotter TB, Jaremko G, Thalme B: Kidney morphological changes in relation to long-term renal function and metabolic control in adolescents with IDDM. Diabetologia 41: 1047-1056, 1998
36. Lurbe E, Redon J, Kesani A, Pascual JM, Tacons J, Alvarez V, Batlle D: Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med 347: 797-805, 2002
37. Barri YM: Hypertension and kidney disease: A deadly connection. Curr Cardiol Rep 8: 411-417, 2006
38. Crook ED, Patel SR: Diabetic nephropathy in African-American patients. Curr Diab Rep 4: 455-461, 2004
39. Powers DR, Wallin JD: End-stage renal disease in specific ethnic and racial groups: Risk factors and benefits of antihypertensive therapy. Arch Intern Med 158: 793-800, 1998
40. Campese VM: Salt sensitivity in hypertension. Renal and cardiovascular implications. Hypertension 23: 531-550, 1994
41. Weir MR: Impact of salt intake on blood pressure and proteinuria in diabetes: Importance of the renin-angiotensin system. Miner Electrolyte Metab 24: 438-445, 1998
42. Trevisan R, Bruttomesso D, Vedovato M, Brocco S, Pianta A, Mazzon C, Girardi C, Jori E, Semplicini A, Tiengo A, Del Prato S: Enhanced responsiveness of blood pressure to sodium intake and to angiotensin II is associated with insulin resistance in IDDM patients with microalbuminuria. Diabetes 47: 1347-1353, 1998
43. Vedovato M, Lepore G, Coracina A, Dodesini AR, Jori E, Tiengo A, Del Prato S, Trevisan R: Effect of sodium intake on blood pressure and albuminuria in type 2 diabetic patients: The role of insulin resistance. Diabetologia 47: 300-303, 2004
44. Giner V, Coca A, de la Sierra A: Increased insulin resistance in salt sensitive essential hypertension. J Hum Hypertens 15: 481-485, 2001
45. Endlich N, Kress KR, Reiser J, Uttenweiler D, Kriz W, Mundel P, Endlich K: Podocytes respond to mechanical stress in vitro. J Am Soc Nephrol 12: 413-422, 2001
46. Eng E, Ballermann BJ: Diminished NF-kappaB activation and PDGF-B expression in glomerular endothelial cells subjected to chronic shear stress. Microvasc Res 65: 137-144, 2003
47. Gruden G, Zonca S, Hayward A, Thomas S, Maestrini S, Gnudi L, Viberti GC: Mechanical stretch-induced fibronectin and transforming growth factor-beta1 production in human mesangial cells is p38 mitogen-activated protein kinase-dependent. Diabetes 49: 655-661, 2000
48. Cortes P, Mendez M, Riser BL, Guerin CJ, Rodriguez-Barbero A, Hassett C, Yee J: F-actin fiber distribution in glomerular cells: Structural and functional implications. Kidney Int 58: 2452-2461, 2000
49. Cortes P, Riser BL, Zhao X, Narins RG: Glomerular volume expansion and mesangial cell mechanical strain: mediators of glomerular pressure injury. Kidney Int Suppl 45: S11-S16, 1994
50. Cortes P, Zhao X, Riser BL, Narins RG: Regulation of glomerular volume in normal and partially nephrectomized rats. Am J Physiol 270: F356-F370, 1996
51. Joost HG, Bell GI, Best JD, Birnbaum MJ, Charron MJ, Chen YT, Doege H, James DE, Lodish HF, Moley KH, Moley JF, Mueckler M, Rogers S, Schurmann A, Seino S, Thorens B: Nomenclature of the GLUT/SLC2A family of sugar/polyol transport facilitators. Am J Physiol Endocrinol Metab 282: E974-E976, 2002
52. Mueckler M: Facilitative glucose transporters. Eur J Biochem 219: 713-725, 1994
53. Heilig CW, Brosius FC, Henry DN: Glucose transporters of the glomerulus and the implications for diabetic nephropathy. Kidney Int 52[Suppl 60]: S91-S99, 1997
54. Li Y, Liu Z, Liu D, Zhang J, Chen Z, Li L: Identification and function of glucose transporter 1 in human mesangial cells. Chin Med J (Engl) 114: 824-828, 2001
55. Heilig CW, Concepcion LA, Riser BL, Freytag SO, Zhu M, Cortes P: Overexpression of glucose transporters in rat mesangial cells cultured in a normal glucose milieu mimics the diabetic phenotype. J Clin Invest 96: 1802-1814, 1995
56. Heilig CW, Kreisberg JI, Freytag S, Murakami T, Ebina Y, Guo L, Heilig K, Loberg R, Qu X, Jin Y, Henry D, Brosius FC 3rd: Antisense GLUT-1 protects mesangial cells from glucose induction of GLUT-1 and fibronectin expression. Am J Physiol Renal Physiol 280: F657-F666, 2001
57. Chen S, Heilig KO, Brosius FC 3rd, Heilig CW: Diabetes increases glomerular Glut1, and antisense-Glut1 protects against diabetic glomerulosclerosis [Abstract]. J Am Soc Nephrol 14: 46A, 2003
58. Heilig KO, Chen S, Xiang M, Brosius FC, Heilig CW: Transgenic overexpression of Glut1 in glomeruli produces feature of diabetic nephropathy in mice [Abstract]. J Am Soc Nephrol 15: 263A, 2004
59. Inoki K, Haneda M, Maeda S, Koya D, Kikkawa R: TGF-beta 1 stimulates glucose uptake by enhancing GLUT1 expression in mesangial cells. Kidney Int 55: 1704-1712, 1999
60. Zhang J, Liu Z, Liu H, Li Y, Li L: Regulation of the expression and function of glucose transporter-1 by TGF-beta 1 and high glucose in mesangial cells. Chin Med J (Engl) 113: 508-513, 2000
61. Nose A, Mori Y, Uchiyama-Tanaka Y, Kishimoto N, Maruyama K, Matsubara H, Iwasaka T: Regulation of glucose transporter (GLUT1) gene expression by angiotensin II in mesangial cells: Involvement of HB-EGF and EGF receptor transactivation. Hypertens Res 26: 67-73, 2003
62. Otsuka F, Yamauchi T, Kataoka H, Mimura Y, Ogura T, Makino H: Effects of chronic inhibition of ACE and AT1 receptors on glomerular injury in Dahl salt-sensitive rats. Am J Physiol 274: R1797-R1806, 1998
63. Ricci C, Iacobini C, Oddi G, Amadio L, Menini S, Rastaldi MP, Frasheri A, Pricci F, Pugliese F, Pugliese G: Role of TGF-beta/GLUT1 axis in susceptibility vs resistance to diabetic glomerulopathy in the Milan rat model. Nephrol Dial Transplant 21: 1514-1524, 2006
64. Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820, 2001
65. King GL, Kunisaki M, Nishio Y, Inoguchi T, Shiba T, Xia P: Biochemical and molecular mechanisms in the development of diabetic vascular complications. Diabetes 45[Suppl 3]: S105-108, 1996
66. Kolm-Litty V, Sauer U, Nerlich A, Lehmann R, Schleicher ED: High glucose induced transforming growth factor beta 1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cell. J Clin Invest 101: 160-169, 1998
67. Adhikary L, Chow F, Nikolic-Paterson DJ, Stambe C, Dowling J, Atkins RC, Tesch GH: Abnormal p38 mitogen-activated protein kinase signalling in human and experimental diabetic nephropathy. Diabetologia 47: 1210-1222, 2004
68. Burt DJ, Gruden G, Thomas SM, Tutt P, Dell'Anna C, Viberti GC, Gnudi L: P38 mitogen-activated protein kinase mediates hexosamine-induced TGFbeta1 mRNA expression in human mesangial cells. Diabetologia 46: 531-537, 2003
69. Igarashi M, Wakasaki H, Takahara N, Ishii H, Jiang ZY, Yamauchi T, Kuboki K, Meier M, Rhodes CJ, King GL: Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways. J Clin Invest 103: 185-195, 1999
70. Koya D, King GL: Protein kinase C activation and the development of diabetic complications. Diabetes 47: 859-866, 1998
71. Henry DN, Busik JV, Brosius FC 3rd, Heilig CW: Glucose transporters control gene expression of aldose reductase, PKCalpha, and GLUT1 in mesangial cells in vitro. Am J Physiol 277: F97-F104, 1999
72. Becker BN, Yasuda T, Kondo S, Vaikunth S, Homma T, Harris RC: Mechanical stretch/relaxation stimulates a cellular renin-angiotensin system in cultured rat mesangial cells. Exp Nephrol 6: 57-66, 1998
73. Weigert C, Brodbeck K, Klopfer K, Haring HU, Schleicher ED: Angiotensin II induces human TGF-beta 1 promoter activation: Similarity to hyperglycaemia. Diabetologia 45: 890-898, 2002
74. D'Agord SB, Lacchini S, Bertoluci MC, Irigoyen MC, Machado UF, Schmid H: Increased renal GLUT1 abundance and urinary TGF-beta 1 in streptozotocin-induced diabetic rats: Implications for the development of nephropathy complicating diabetes. Horm Metab Res 33: 664-669, 2001
75. D'Agord Schaan B, Lacchini S, Bertoluci MC, Irigoyen MC, Machado UF, Schmid H: Impact of renal denervation on renal content of GLUT1, albuminuria and urinary TGF-beta1 in streptozotocin-induced diabetic rats. Auton Neurosci 104: 88-94, 2003
76. Depre C, Young ME, Ying J, Ahuja HS, Han Q, Garza N, Davies PJ, Taegtmeyer H: Streptozotocin-induced changes in cardiac gene expression in the absence of severe contractile dysfunction. J Mol Cell Cardiol 32: 985-996, 2000
77. Hirsch B, Rosen P: Diabetes mellitus induces long lasting changes in the glucose transporter of rat heart endothelial cells. Horm Metab Res 31: 645-652, 1999
78. Badr GA, Tang J, Ismail-Beigi F, Kern TS: Diabetes downregulates GLUT1 expression in the retina and its microvessels but not in the cerebral cortex or its microvessels. Diabetes 49: 1016-1021, 2000
79. Heilig CW, Liu Y, England RL, Freytag SO, Gilbert JD, Heilig KO, Zhu M, Concepcion LA, Brosius FC 3rd: D-glucose stimulates mesangial cell Glut1 expression and basal and IGF-I-sensitive glucose uptake in rat mesangial cell. Diabetes 46: 1030-1039, 1997
80. Howard RL: Down-regulation of glucose transport by elevated extracellular glucose concentrations in cultured rat aortic smooth muscle cells does not normalize intracellular glucose concentrations. J Lab Clin Med 127: 504-515, 1996
81. Liu Z, Chen Z, Li Y: Phenotypic and functional alterations of mesangial cells in patients with diabetic nephropathy. Zhonghua Yi Xue Za Zhi 81: 1369-1373, 2001
82. Ciaraldi TP, Mudaliar S, Barzin A, Macievic JA, Edelman SV, Park KS, Henry RR: Skeletal muscle GLUT1 transporter protein expression and basal leg glucose uptake are reduced in type 2 diabetes. J Clin Endocrinol Metab 90: 352-358, 2005
83. Praga M, Morales E: Obesity, proteinuria and progression of renal failure. Curr Opin Nephrol Hypertens 15: 481-486, 2006
84. Wu Y, Liu Z, Xiang Z, Zeng C, Chen Z, Ma X, Li L: Obesity-related glomerulopathy: Insights from gene expression profiles of the glomeruli derived from renal biopsy samples. Endocrinology 147: 44-50, 2006
85. Rich SS: Genetics of diabetes and its complications. J Am Soc Nephrol 17: 353-360, 2006
86. Zintzaras E, Stefanidis I: Association between the GLUT1 gene polymorphism and the risk of diabetic nephropathy: A meta-analysis. J Hum Genet 50: 84-91, 2005
87. Hodgkinson AD, Page T, Millward BA, Demaine AG: A novel polymorphism in the 5′ flanking region of the glucose transporter (GLUT1) gene is strongly associated with diabetic nephropathy in patients with type 1 diabetes mellitus. J Diabetes Complications 19: 65-69, 2005
88. Liu Z, Guan T, Chen Z: Insulin receptor substrate-1 and glucose transporter gene polymorphisms in noninsulin-dependent diabetes mellitus. Zhonghua Yi Xue Za Zhi 78: 662-665, 1998
89. Imperatore G, Hanson RL, Pettitt DJ, Kobes S, Bennett PH, Knowler WC: Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Pima Diabetes Genes Group. Diabetes 47: 821-830, 1998
90. Iyengar SK, Fox KA, Schachere M, Manzoor F, Slaughter ME, Covic AM, Orloff SM, Hayden PS, Olson JM, Schelling JR, Sedor JR: Linkage analysis of candidate loci for endstage renal disease due to diabetic nephropathy. J Am Soc Nephrol 14[Suppl]: S195-S201, 2003
91. Lindner TH, Monks D, Wanner C, Berger M: Genetic aspects of diabetic nephropathy. Kidney Int Suppl 84: S186-S191, 2003
92. Moczulski DK, Rogus JJ, Antonellis A, Warram JH, Krolewski AS: Major susceptibility locus for nephropathy in type 1 diabetes on chromosome 3q: Results of novel discordant sib-pair analysis. Diabetes 47: 1164-1169, 1998
93. Vardarli I, Baier LJ, Hanson RL, Akkoyun I, Fischer C, Rohmeiss P, Basci A, Bartram CR, van der Woude FJ, Janssen B: Gene for susceptibility to diabetic nephropathy in type 2 diabetes maps to 18q22.3-23. Kidney Int 62: 2176-2183, 2002